Arterys Cardio DL vs AI-CVD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by ARTERYS
VS
by HeartLung Corporation

AI Verdict

Arterys Cardio DL specializes in detailed cardiac MRI analysis, providing automated ventricle segmentations and advanced features like 4D Flow for in-depth diagnostics. In contrast, AI-CVD focuses on opportunistic screening for cardiovascular risks using existing CT scans, identifying conditions such as coronary artery calcium without requiring additional imaging. While both are FDA-cleared, cloud-based Cardiology AI tools, they cater to different imaging modalities and distinct points in the patient care pathway.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is advanced, detailed analysis of cardiac MRI studies. This tool excels at providing automated, editable ventricle segmentations, 4D Flow post-processing for blood flow visualization, and quantitative delayed enhancement analysis, significantly enhancing diagnostic accuracy and reducing interpretation time for complex cardiac MRI cases.

View Arterys Cardio DL →

Choose AI-CVD if…

Choose AI-CVD if your goal is opportunistic screening for cardiovascular and multisystem diseases using existing CT scans. This platform is ideal for leveraging routine chest and abdominal CTs to automatically identify hidden health risks like coronary artery calcium and aortic calcifications, without requiring additional imaging, radiation, or workflow disruption.

View AI-CVD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Arterys Cardio DL AI-CVD
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based Cloud
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Arterys Cardio DL

Arterys Cardio DL (Tool A) offers automated, editable ventricle segmentations and rapid analysis, significantly reducing interpretation time. The ability to edit automated contours provides users with control and fine-tuning capabilities, enhancing the overall user experience in a diagnostic context.

Clinical Value

Tie

Both tools offer substantial clinical value but in different domains. Arterys Cardio DL (Tool A) enhances diagnostic accuracy through detailed cardiac MRI analysis, including 4D Flow post-processing and quantitative Delayed Enhancement. AI-CVD (Tool B) provides broad opportunistic screening for cardiovascular and multisystem diseases from existing CT scans, enabling early detection of hidden health risks across a wider patient population.

Pricing & Value

Tie

Both tools require contacting the vendor for pricing, making a direct cost comparison impossible. While Arterys Cardio DL (Tool A) offers value through reduced interpretation time, AI-CVD (Tool B) emphasizes leveraging existing CT scans without additional imaging or workflow disruption, implying inherent cost savings and efficiency. Without transparent pricing, it's difficult to definitively assess which offers superior value.

Enterprise Readiness

Arterys Cardio DL

Arterys Cardio DL (Tool A) explicitly states FDA clearance, HIPAA compliance, BAA availability, and vendor-agnostic compatibility, which are critical for enterprise adoption. AI-CVD (Tool B) states 'likely, contact vendor' for BAA and HIPAA, introducing a degree of uncertainty compared to Tool A's definitive claims.

Innovation

Tie

Arterys Cardio DL (Tool A) is noted as the 'world's first internet platform for medical imaging' and leverages deep learning for advanced cardiac MRI analysis, showcasing foundational innovation in delivery and technology. AI-CVD (Tool B) presents a highly innovative approach by performing opportunistic screening for multiple diseases from existing CT scans without workflow disruption, offering significant potential for population health impact.

Support & Docs

Arterys Cardio DL

While specific documentation details are limited for both, Arterys (Tool A) publicly emphasizes customer success, support, training, and implementation, indicating a more robust support infrastructure. HeartLung Corporation (Tool B) provides a 'contact us' option but less explicit information regarding dedicated support resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Arterys Cardio DL AI-CVD
Tool Name Arterys Cardio DL AI-CVD
Company ARTERYS HeartLung Corporation
Primary Imaging Modality Cardiac MRI CT scans (existing chest and abdominal)
Core Functionality Automated, editable ventricle segmentations for cardiac MRI analysis Opportunistic screening for cardiovascular and multisystem diseases using existing CT scans
Key Analysis/Measurements Automated ventricle segmentations, 4D Flow post-processing, Quantitative Delayed Enhancement analysis Coronary Artery Calcium (CAC) scoring, Aortic wall/valve/mitral valve calcium analysis, Cardiac chamber volumetry, Epicardial fat volumetry, Aorta and pulmonary artery sizing

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and AI-CVD.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Arterys Cardio DL is designed for cardiac MRI analysis, providing automated ventricle segmentations. In contrast, AI-CVD performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, specifically chest and abdominal CTs.
Arterys Cardio DL aims to drastically reduce interpretation time and enhance diagnostic accuracy for cardiac MRI analysis, including 4D Flow post-processing. AI-CVD focuses on early detection of hidden health risks through opportunistic screening from existing CT scans, identifying potential issues like coronary heart disease, heart failure, and stroke.
Arterys Cardio DL offers automated ventricle segmentations, 4D Flow post-processing for blood flow visualization and quantification, and Quantitative Delayed Enhancement analysis. AI-CVD provides automated CT-derived measurements such as Coronary Artery Calcium (CAC) scoring, aortic/mitral valve calcium analysis, cardiac chamber volumetry, and epicardial fat volumetry.
Arterys Cardio DL processes cardiac MRI data to enhance analysis efficiency. AI-CVD is designed for opportunistic screening using *existing* CT scans, meaning it requires no additional imaging, radiation, contrast, or workflow disruption.
Arterys Cardio DL offers rapid analysis, reducing interpretation time from 30-60 minutes to seconds, and provides editable automated contours for precise and consistent ventricular function. AI-CVD enables early detection of cardiovascular and multisystem diseases from existing scans, potentially identifying risks that patients are unaware of, without additional imaging burden.
AI Tool Finder
AI-powered search. Results may not be comprehensive.